バイオアナリシス検査サービスの世界市場レポート 2024

バイオアナリシス検査サービスの市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には9.5%の年間複合成長率（CAGR）で49億9,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、バイオ医薬品パイプラインの拡大、バイオシミラーの開発増加、精密医療の進歩、臨床試験の複雑さの増大によって促進されます。この期間に予想される主な動向には、人工知能（AI）の統合、包括的な薬物動向分析、マイクロバイオーム分析サービス、ハイスループット技術の採用、生体サンプル分析などが含まれます。

感染症の発生抑制を目的とした政府の取り組みの拡大は、バイオアナリシス検査サービス市場の拡大を促進する上で重要な役割を果たしています。新型コロナウイルス感染症（COVID-19）のパンデミックの発生により、バイオアナリシス検査サービスへの需要が特に高まっており、世界中の国々が病気の蔓延を防ぎ、影響を軽減するために積極的な対策を講じ、支出を増やすよう促されています。わかりやすい例は、2021年3月の米国保健福祉省の発表で、学校を安全に再開するためのスクリーニング検査を強化するためのアメリカン・レスキュー・プランからの100億米ドルの投資を詳述しています。さらに、十分なサービスを受けられていない集団に対する検査を拡大するために22億5,000万米ドルが割り当てられました。政府の取り組みに対するこの財政的関与の強化は、バイオアナリシス検査サービス市場の継続的な成長に大きく貢献すると予想されます。

慢性疾患の有病率の拡大により、近い将来バイオアナリシス検査サービス市場の成長が促進されると予想されます。慢性疾患は、3か月以上持続する病気を特徴とし、時間の経過とともに悪化する可能性があるため、効果的な診断および監視ツールが必要です。 バイオアナリシス検査サービスは、慢性疾患に関連する特定のバイオマーカーを特定および測定する際に重要な役割を果たし、治療薬のモニタリングを支援して、治療範囲内の最適な薬剤レベルを確保します。一例として、国立医学図書館は2023年 1月に、少なくとも1つの慢性疾患を持つ米国の50歳以上の人の数が99.5%増加し、2050年までに1億4,266万人に達すると予測されていると報告しました。世界保健機関が2022年9月に発表した2022年のハイライトでは、年間4,100万人に上る全世界の死亡者数の74％が非感染性疾患（NCD）または慢性疾患に起因していることが明らかになった。この慢性疾患の有病率の急増は、バイオアナリシス検査サービス市場の成長を推進する重要な原動力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のバイオアナリシス検査サービス市場、検査タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ADME（吸収、流通、代謝、排泄）
• 薬物動態学
• 薬力学
• 生物学的同等性
• バイオアベイラビリティ
• 世界のバイオアナリシス検査サービス市場、分子タイプ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 低分子
• 高分子
• 世界のバイオアナリシス検査サービス市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 製薬会社およびバイオ医薬品会社
• 受託開発・製造組織
• 受託研究機関

第7章 地域および国の分析

• 世界のバイオアナリシス検査サービス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のバイオアナリシス検査サービス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バイオアナリシス検査サービス市場の競合情勢
• バイオアナリシス検査サービス市場の企業プロファイル
  • CD BioSciences
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Laboratory Corporation of America Holdings（LabCorp）
  • Eurofins Scientific SE

第31章 その他の大手および革新的な企業

• ICON plc
• PPD Inc.
• SGS SA
• WuXi AppTec
• Syneos Health Inc.
• STERIS plc
• Sartorius AG
• Charles River Laboratories Inc.
• Intertek Group
• Covance Inc.
• PAREXEL International Corporation
• Element Materials Technology
• ALS Limited
• Medpace Holdings Inc.
• Almac Group

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Bioanalytical testing services encompass cutting-edge methodologies for quantifying analytes. These services play a pivotal role in identifying and characterizing pharmaceuticals and metabolites within biological fluids such as blood, plasma, serum, urine, or tissue extracts.

Bioanalytical testing services encompass various essential tests, including ADME (absorption, distribution, metabolism, and excretion), pharmacokinetic, pharmacodynamic, bioequivalence, and bioavailability assessments. ADME examines how a chemical undergoes absorption, distribution, metabolism, and excretion within a living organism, crucial for understanding drug processing. It aids in evaluating safety, toxicity, and the viability of drugs, offering precise targets for future research and development endeavors. These testing services analyze both small and large molecules, catering to pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, as well as contract research organizations. They serve as indispensable tools in drug development and assessment, providing vital insights into a compound's behavior within biological systems.

The bioanalytical testing services market research report is one of a series of new reports from The Business Research Company that provides bioanalytical testing services market statistics, including bioanalytical testing services industry global market size, regional shares, competitors with a bioanalytical testing services market share, detailed bioanalytical testing services market segments, market trends and opportunities, and any further data you may need to thrive in the bioanalytical testing services industry. This bioanalytical testing services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioanalytical testing services market size has grown strongly in recent years. It will grow from $3.23 billion in 2023 to $3.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. Historical growth can be attributed to the globalization of clinical studies, emphasis on pharmacokinetics, implementation of quality control measures, and the increasing focus on personalized medicine.

The bioanalytical testing services market size is expected to see strong growth in the next few years. It will grow to $4.99 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. Anticipated growth in the forecast period is fueled by the expansion of the biopharmaceutical pipeline, increased development of biosimilars, advancements in precision medicine, and the growing complexity of clinical trials. Key trends expected in this period involve the integration of artificial intelligence (AI), comprehensive pharmacokinetic analysis, services for microbiome analysis, adoption of high-throughput technologies, and biological sample analysis.

The growing government initiatives aimed at controlling infectious disease outbreaks are playing a significant role in propelling the expansion of the bioanalytical testing services market. The onset of the COVID-19 pandemic has particularly heightened the demand for bioanalytical testing services, prompting countries worldwide to take proactive measures and increase expenditures to prevent the spread and mitigate the impact of diseases. An illustrative example is the U.S. Department of Health and Human Services' announcement in March 2021, detailing an investment of $10 billion from the American Rescue Plan to bolster screening testing for the safe reopening of schools. Additionally, $2.25 billion was allocated to scale up testing in underserved populations. This increased financial commitment to government initiatives is expected to significantly contribute to the continued growth of the bioanalytical testing services market.

The escalating prevalence of chronic diseases is anticipated to drive the growth of the bioanalytical testing services market in the foreseeable future. Chronic diseases, characterized by enduring illness lasting three months or more and with the potential to worsen over time, necessitate effective diagnostic and monitoring tools. Bioanalytical testing services play a crucial role in identifying and measuring specific biomarkers associated with chronic diseases, aiding in therapeutic drug monitoring to ensure optimal drug levels within the therapeutic range. As an example, the National Library of Medicine reported in January 2023 that the number of individuals in the US aged 50 and older with at least one chronic condition is projected to increase by 99.5%, reaching 142.66 million by 2050. Furthermore, according to the World Health Organization's 2022 Highlights in September 2022, 74% of all global deaths, amounting to 41 million annually, result from noncommunicable diseases (NCDs) or chronic diseases. This surge in chronic diseases' prevalence is a key driver propelling the growth of the bioanalytical testing services market.

Major companies within the bioanalytical testing services market are actively pursuing advanced solutions, exemplified by the introduction of technologies such as reverse transcription PCR (RT-PCR) tests, to fortify their market positions. RT-PCR is a laboratory technique involving the conversion of RNA into complementary DNA (cDNA) using the reverse transcriptase enzyme. A case in point is Eurofins Scientific SE, a France-based testing laboratory company, which, in June 2023, launched the NovaType SARS-CoV-2 RT-PCR assay. This clinically validated assay offers a short turnaround time, making it well-suited for the re-testing of millions of positive samples to identify specific virus variants. The NovaType SARS-CoV-2 RT-PCR assay, functioning in real-time, is designed for the qualitative detection of SARS-CoV-2, the virus responsible for COVID-19, and the subsequent identification of specific variants, including B.1.1.7 and B.1.351. This strategic focus on advanced solutions underscores the commitment of major companies to staying at the forefront of technological advancements in the bioanalytical testing services market.

Major companies in the bioanalytical testing services market are strategically investing in the development of advanced testing facilities as part of their efforts to sustain and enhance their market positions. Testing facilities, specialized environments equipped for conducting diverse tests on products, materials, systems, or components, play a pivotal role in ensuring accurate and reliable results. In October 2021, Thermo Fisher Scientific Inc., a prominent US-based biotechnology company, exemplified this strategic focus by launching a State-of-the-Art Bioanalytical Lab. This specialized facility is dedicated to bioanalytical services, involving the analysis of biological samples such as blood or tissue to detect and quantify drugs, metabolites, biomarkers, and other molecules. The lab is equipped with cutting-edge technologies, including liquid chromatography-mass spectrometry (LC-MS), which enables highly sensitive and specific analysis of drugs and other molecules. This emphasis on developing state-of-the-art testing facilities underscores the commitment of major companies to delivering high-quality bioanalytical testing services and maintaining a competitive edge in the market.

In February 2022, Eurofins Scientific, a France-based laboratory service company, announced the acquisition of Genetic Testing Service JSC for an undisclosed amount. This strategic move is expected to facilitate Eurofins' expansion in the clinical genetic testing market and complement its global network of clinical diagnostics laboratories. Genetic Testing Service JSC, based in Vietnam, is a company specializing in genetic testing services, including specialized DNA testing, genealogical DNA tests, and testing for conditions such as cancer and COVID-19.

Major companies operating in the bioanalytical testing services market report are CD BioSciences, Thermo Fisher Scientific Inc., Merck KGaA, Laboratory Corporation of America Holdings (Labcorp), Eurofins Scientific SE, ICON PLC, PPD Inc., SGS SA, WuXi AppTec, Syneos Health Inc., STERIS PLC, Sartorius AG, Charles River Laboratories Inc., Intertek Group, Covance Inc., PAREXEL International Corporation, Element Materials Technology, ALS Limited, Medpace Holdings Inc., Almac Group, Pace Analytical Services LLC, Altasciences, BioAgilytix Labs, Frontage Laboratories Inc., Cinven Ltd. (LGC Limited), Toxikon Inc., Absorption Systems LLC, Lotus Labs Pvt. Ltd., Bioneeds India Private Limited, Vipragen Biosciences Pvt. Ltd., Source BioScience

North America was the largest region in the bioanalytical testing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioanalytical testing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioanalytical testing services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioanalytical testing services market includes revenues earned by entities by providing services such as method development, high throughput sample analysis, method validation, and pharmacokinetic and toxicokinetic support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioanalytical Testing Services Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioanalytical testing services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioanalytical testing services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioanalytical testing services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Test Type: ADME (Absorption, Distribution, Metabolism, And Excretion); Pharmacokinetic; Pharmacodynamic; Bioequivalence; Bioavailability
• 2) By Molecule Type: Small Molecules; Large Molecules
• 3) By End User: Pharmaceutical And Biopharmaceutical Companies; Contract Development And Manufacturing Organizations; Contract Research Organizations
• Companies Mentioned: CD BioSciences; Thermo Fisher Scientific Inc.; Merck KGaA; Laboratory Corporation of America Holdings (Labcorp); Eurofins Scientific SE
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioanalytical Testing Services Market Characteristics

3. Bioanalytical Testing Services Market Trends And Strategies

4. Bioanalytical Testing Services Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Bioanalytical Testing Services Market Size and Growth

• 5.1. Global Bioanalytical Testing Services Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Bioanalytical Testing Services Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Bioanalytical Testing Services Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Bioanalytical Testing Services Market Segmentation

• 6.1. Global Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• ADME (Absorption, Distribution, Metabolism, And Excretion)
• Pharmacokinetic
• Pharmacodynamic
• Bioequivalence
• Bioavailability
• 6.2. Global Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Small Molecules
• Large Molecules
• 6.3. Global Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pharmaceutical And Biopharmaceutical Companies
• Contract Development And Manufacturing Organizations
• Contract Research Organizations

7. Bioanalytical Testing Services Market Regional And Country Analysis

• 7.1. Global Bioanalytical Testing Services Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Bioanalytical Testing Services Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Bioanalytical Testing Services Market

• 8.1. Asia-Pacific Bioanalytical Testing Services Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Bioanalytical Testing Services Market

• 9.1. China Bioanalytical Testing Services Market Overview
• 9.2. China Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Bioanalytical Testing Services Market

• 10.1. India Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Bioanalytical Testing Services Market

• 11.1. Japan Bioanalytical Testing Services Market Overview
• 11.2. Japan Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Bioanalytical Testing Services Market

• 12.1. Australia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Bioanalytical Testing Services Market

• 13.1. Indonesia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Bioanalytical Testing Services Market

• 14.1. South Korea Bioanalytical Testing Services Market Overview
• 14.2. South Korea Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Bioanalytical Testing Services Market

• 15.1. Western Europe Bioanalytical Testing Services Market Overview
• 15.2. Western Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Bioanalytical Testing Services Market

• 16.1. UK Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Bioanalytical Testing Services Market

• 17.1. Germany Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Bioanalytical Testing Services Market

• 18.1. France Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Bioanalytical Testing Services Market

• 19.1. Italy Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19. 2. Italy Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Bioanalytical Testing Services Market

• 20.1. Spain Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Bioanalytical Testing Services Market

• 21.1. Eastern Europe Bioanalytical Testing Services Market Overview
• 21.2. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Bioanalytical Testing Services Market

• 22.1. Russia Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Bioanalytical Testing Services Market

• 23.1. North America Bioanalytical Testing Services Market Overview
• 23.2. North America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Bioanalytical Testing Services Market

• 24.1. USA Bioanalytical Testing Services Market Overview
• 24.2. USA Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Bioanalytical Testing Services Market

• 25.1. Canada Bioanalytical Testing Services Market Overview
• 25.2. Canada Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Bioanalytical Testing Services Market

• 26.1. South America Bioanalytical Testing Services Market Overview
• 26.2. South America Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Bioanalytical Testing Services Market

• 27.1. Brazil Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Bioanalytical Testing Services Market

• 28.1. Middle East Bioanalytical Testing Services Market Overview
• 28.2. Middle East Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Bioanalytical Testing Services Market

• 29.1. Africa Bioanalytical Testing Services Market Overview
• 29.2. Africa Bioanalytical Testing Services Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Bioanalytical Testing Services Market, Segmentation By Molecule Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Bioanalytical Testing Services Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Bioanalytical Testing Services Market Competitive Landscape And Company Profiles

• 30.1. Bioanalytical Testing Services Market Competitive Landscape
• 30.2. Bioanalytical Testing Services Market Company Profiles
  • 30.2.1. CD BioSciences
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Thermo Fisher Scientific Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Merck KGaA
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Laboratory Corporation of America Holdings (LabCorp)
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Eurofins Scientific SE
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Bioanalytical Testing Services Market Other Major And Innovative Companies

• 31.1. ICON plc
• 31.2. PPD Inc.
• 31.3. SGS SA
• 31.4. WuXi AppTec
• 31.5. Syneos Health Inc.
• 31.6. STERIS plc
• 31.7. Sartorius AG
• 31.8. Charles River Laboratories Inc.
• 31.9. Intertek Group
• 31.10. Covance Inc.
• 31.11. PAREXEL International Corporation
• 31.12. Element Materials Technology
• 31.13. ALS Limited
• 31.14. Medpace Holdings Inc.
• 31.15. Almac Group

32. Global Bioanalytical Testing Services Market Competitive Benchmarking

33. Global Bioanalytical Testing Services Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Bioanalytical Testing Services Market

35. Bioanalytical Testing Services Market Future Outlook and Potential Analysis

• 35.1 Bioanalytical Testing Services Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Bioanalytical Testing Services Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Bioanalytical Testing Services Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer